An Open-label Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of EDG-7500 in Adults with Hypertrophic Cardiomyopathy

Brief description of study

The purpose of this study is to learn about the safety and tolerability of an investigational study drug called EDG-7500 for the treatment of hypertrophic cardiomyopathy (HCM).

The study will also measure levels of study drug and any possible metabolites (break-down products of the study drug) and biological markers (biomarkers) in the blood. Biomarkers are substances in your blood that help us understand how the body is reacting to the study drug.

Clinical Study Identifier: s24-01005

ClinicalTrials.gov Identifier: NCT06347159

Principal Investigator: Daniele Massera.

Other Investigators: Mark V. Sherrid, Kristen Marie Rodriguez, Woon Yee Wu, Maria Reuter.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies